Werewolf transforms into Ambros via reverse merger to support phase 3 push for rare disease drug

M&A — Werewolf transforms into Ambros via reverse merger to support phase 3 push for rare disease drug  Fierce Biotech

Read the original at M&A ↗

Auto-published by the finit.news Events monitor from M&A; summarized by AI and may contain errors — verify against the primary source. August 21, 2026.